Sucraid sacrosidase fda approval status?

Is Sucraid (sacrosidase) approved by the FDA?

Yes. Sucraid (sacrosidase) is an FDA-approved prescription medicine for the treatment of congenital sucrase-isomaltase deficiency (CSID) in patients who cannot tolerate sucrose. [1]

What is Sucraid approved to treat?

Sucraid is indicated for congenital sucrase-isomaltase deficiency (CSID), where it helps manage the condition by breaking down sucrose. [1]

What form does Sucraid come in, and who is it for?

Sucraid is a liquid oral medication used in patients with CSID. FDA labeling describes use for patients who cannot tolerate sucrose as part of their CSID management. [1]

When did FDA approve Sucraid?

The FDA approval date (and related history) is provided in the FDA product labeling/entry for Sucraid. [1]

Sources

1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020888